Search

Ihor Andrew Terleckyj

from Berwyn, PA
Age ~65
Get Report
Also known as:
Ihor A Terleckyj, Ia Terleckyj, Ihor Terleck, Ihor A Terlecky, Ihor Terleckyi, Ihor J
Phone and address:
928 Pinecroft Rd, Berwyn, PA 19312
(610) 647-2681
Related to:
Jozef Janak, 54Katria B Czerwoniak, 86Chrystyna I Lazirko, 35Familytrust CzerwoniakChrystyna Z Janak, 62Andrew A Lazirko, 32Z S TerleckyJaroslaw Czerwoniak, 92Olenia M Czerwoniak, 57
Connected to:
Joan L Terlecky, 67Joao Terlecki, 57Shirley A Terlecki, 72Frank M Terlep, 80James L Terlep, 76John F Terlep, 57Mark K Terlep, 59William J Terlep, 68Natalie Terletsky, 51John G Terlingo, 58

Ihor Terleckyj Phones & Addresses

  • 928 Pinecroft Rd, Berwyn, PA 19312 (610) 647-2681
  • 15 Darling Ave, Bloomfield, NJ 07003 (973) 771-1156
  • 333 Ridgewood Ave, Ridgewood, NJ 07450 (201) 251-4281
  • Ramsey, NJ
  • 70 John F Kennedy Blvd, Somerset, NJ 08873
  • Chester, PA
  • Paoli, PA
  • 928 Pinecroft Rd, Berwyn, PA 19312 (201) 406-0861

Industries

Pharmaceuticals

Resumes

Resumes

Ihor Terleckyj Photo 1

Ihor Terleckyj

View page
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals

Publications

Us Patents

Glucose And Lipid Lowering Compounds

View page
US Patent:
6509480, Jan 21, 2003
Filed:
Oct 23, 2001
Appl. No.:
10/047182
Inventors:
Dilip R. Wagle - Nanuet NY
Sheng Ding Fang - Mahwah NJ
Ihor Terleckyj - Ridgewood NJ
John Resek - Brooklyn NY
John J. Egan - New York NY
Assignee:
Alteon, Inc. - Ramsey NJ
International Classification:
C07D40700
US Classification:
549299, 548525, 560126, 562510, 562511
Abstract:
Provided are, among other things, lipid-lowering or glucose-lowering methods and compounds, particularly lipid-lowering or glucose-lowering compounds, with an A-B ring structure as follows: wherein the dotted line between carbons 5 and 6, the dotted line between carbon 4 and R , and the dotted line between carbon 11 and R each independently represent an optional double bond from the respective numbered carbon to a linked carbon, and wherein X is hydroxy or, together with Y is oxy linking carbon 8 and carbon 12.

Treatment Of Fatty Liver

View page
US Patent:
20070265340, Nov 15, 2007
Filed:
Jan 5, 2007
Appl. No.:
11/649881
Inventors:
Robert Shalwitz - Bexley OH, US
Roelof Rongen - Califon NJ, US
Ihor Terleckyj - Bloomfield NJ, US
International Classification:
A61K 31/202
A61P 1/16
US Classification:
514560000
Abstract:
Methods and compositions comprising peroxisomal and/or mitochondrial beta oxidation stimulating agents to reverse or resolve, slow the progression of, treat or prevent the development of fatty liver and conditions stemming from fatty liver, such as NASH, liver inflammation, cirrhosis and liver failure. An active agent that by itself is associated with an increased risk of fatty liver development and conditions stemming from fatty liver, such as NASH, liver inflammation, cirrhosis and liver failure, may be administered in combination with peroxisomal and/or mitochondrial beta oxidation stimulating agents. A combination regimen involving such agents, as simultaneous or concomitant therapy, or as a fixed dosage form, is also provided.

Treatment Of Fatty Liver

View page
US Patent:
20090182022, Jul 16, 2009
Filed:
Jan 5, 2007
Appl. No.:
12/087411
Inventors:
Roelof M. L. Rongen - Califon NJ, US
Robert A. Shalwitz - Bexley OH, US
Ihor Terleckyj - Bloomfield NJ, US
International Classification:
A61K 31/20
A61K 31/426
A61P 1/16
US Classification:
514365, 514560
Abstract:
Methods and compositions comprising peroxisomal and/or mitochondrial beta oxidation stimulating agents to reverse or resolve, slow the progression of, treat or prevent the development of fatty liver and conditions stemming from fatty liver, such as NASH, liver inflammation, cirrhosis and liver failure. An active agent that by itself is associated with an increased risk of fatty liver development and conditions stemming from fatty liver, such as NASH, liver inflammation, cirrhosis and liver failure, may be administered in combination with peroxisomal and/or mitochondrial beta oxidation stimulating agents. A combination regimen involving such agents, as simultaneous or concomitant therapy, or as a fixed dosage form, is also provided.

Glucose And Lipid Lowering Compounds

View page
US Patent:
63263963, Dec 4, 2001
Filed:
Nov 12, 1999
Appl. No.:
9/439706
Inventors:
Dilip R. Wagle - Nanuet NY
Sheng Ding Fang - Mahwah NJ
Ihor Terleckyj - Ridgewood NJ
John Resek - Brooklyn NY
John J. Egan - New York NY
Assignee:
Alteon, Inc. - Ramsey NJ
International Classification:
A61K 3134
US Classification:
514468
Abstract:
Provided are, among other things, lipid-lowering or glucose-lowering methods and compounds, particularly lipid-lowering or glucose-lowering compounds, with an A-B ring structure as follows: ##STR1## wherein the dotted line between carbons 5 and 6, the dotted line between carbon 4 and R. sup. 2, and the dotted line between carbon 11 and R. sup. 3 each independently represent an optional double bond from the respective numbered carbon to a linked carbon, and wherein X is hydroxy or, together with Y is oxy linking carbon 8 and carbon 12.

Compositions Comprising Docosapentaenoic Acid And Methods Of Use

View page
US Patent:
20140194512, Jul 10, 2014
Filed:
Mar 12, 2014
Appl. No.:
14/207099
Inventors:
- Bedminster NJ, US
George BOBOTAS - Tarpon Springs FL, US
Ihor TERLECKYJ - Berwyn PA, US
Roelof RONGEN - Califon NJ, US
Assignee:
Matinas BioPharma, Inc. - Bedminster NJ
International Classification:
A61K 31/202
US Classification:
514560
Abstract:
Orally administrable composition comprising fatty acids comprising docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA). The compositions can be used for the treatment or prophylaxis of a variety of conditions, including liver-related conditions.

Omega-3 Pentaenoic Acid Compositions And Methods Of Use

View page
US Patent:
20140107200, Apr 17, 2014
Filed:
Dec 17, 2013
Appl. No.:
14/109338
Inventors:
- BEDMINSTER NJ, US
GEORGE BOBOTAS - TARPON SPRINGS FL, US
IHOR TERLECKYJ - BERWYN PA, US
Assignee:
MATINAS BIOPHARMA, INC. - BEDMINSTER NJ
International Classification:
A61K 31/202
A61K 31/232
US Classification:
514549, 514560
Abstract:
Orally administrable composition comprising fatty acids comprising omega-3-fatty adds, salts or derivatives thereof are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, CNS, inflammatory, and other diseases/conditions or risk factors therefore.

Omega-3 Pentaenoic Acid Compositions And Methods Of Use

View page
US Patent:
20140107206, Apr 17, 2014
Filed:
Dec 17, 2013
Appl. No.:
14/109194
Inventors:
- Bedminster NJ, US
George BOBOTAS - Tarpon Springs FL, US
Ihor TERLECKYJ - Berwyn PA, US
Assignee:
Matinas BioPharma, Inc. - Bedminster NJ
International Classification:
A61K 31/202
US Classification:
514560
Abstract:
Orally administrable composition comprising fatty acids comprising omega-3-fatty acids, salts or derivatives thereof are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, CNS, inflammatory, and other diseases/conditions or risk factors therefore.
Control profile
Ihor Andrew Terleckyj from Berwyn, PA, age ~65 Get Report